<img src="https://ml.globenewswire.com/Resource/Download/afcf3b59-ca71-40ed-9226-a0901bf4d13b?size=2" nborder="0" align="left" hspace="5" vspace="5" title="logo.jpg" alt="Lexicon Pharmaceuticals, Inc."/>THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=cRPo06ZRg7ltKf_ATlEwt_4mz-1tKPh-F5qlYGVpW65AvMpEsXseCy9haP_B0UsIE9ZWTVmUFiy_JL3ID6dawhastUyZK1sF5LOvbrMzOZQHiCBr1-2Zm-Ioy2ZSFgDJmZXLNsJSLJDu27kX7Mb931mRvx5Yxe4Z7GwBM94v9kPh0LpOiLWO48s_EDZFs7ROWTnJHGfTO9VebXj3eHCkdmi8lx1Bv0xpcYQUN0q6Fbe_nDEvARYCebiqOS0pxnFSguE2DhelqEJCOIpq3ZfPKZAkEt48kbAjYiy_aRBwmGhV4BWR7N8CiAbTggmcFPRa" rel="nofollow" target="_blank" title="Lexicon Pharmaceuticals, Inc.">Lexicon Pharmaceuticals, Inc.</a> (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026. The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at <a href="https://www.globenewswire.com/Tracker?data=cFpjOT1CEe_02b0GKwd7plwoYxEZAACnjZraMgVt0dJDSBRqaOzPYOpC7RlnjfbI1cYgkUYbDN4NYNgjnZ_XcraVoxdm4nPeU96oBP5sNLqtuAZtm9crfRL65wTL1MQMjwlyvbwL-ET6aAOHtBBnxWULiWw7Ax6Vn8lTd9KM-fC5TBKD3-64mzyIhQ9M8pa9s4HN6wAOIgMEL5rU8_DAsW7YS0NvDVBqAy_37_ktc3AAGZxMYYokR_9qvgrH3MTM7O5HwMnVuy5jYyaXdzSK-pQAXeE6necfFJEz4klCAfh99ZCRukT9SUHBT8vsujU2" rel="nofollow" target="_blank" title="">https://investors.lexpharma.com/</a>. About Lexicon Pharmaceuticals    Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit <a href="https://www.globenewswire.com/Tracker?data=M7vwXc0iUPVdj3Ri-AxHGF3OEOvCWxW9bZH1COcF0N-lQc18t55Drhgp30Xk-XY9OoWArDiMTR72Spx9ZnmTSYIGT-pttrbazLHEbvztFjEEqKqn4_Aq_RgtbJJt69Qo_i4n4Ip1rSahnSV3pQOPKUWM1GsRSV1asIE7i9wW1RWqWFRiGZusDLKCP9yjbS8n4xuXx-Hb_0OhFiah8LFJZYIl2Aw5h4iL8KSIVuYQL7Afcw-Dx3I8iYrTSc_YXwk0Fm7g6d4gnE0-kTaQLKvEwg==" rel="nofollow" target="_blank" title="www.lexpharma.com">www.lexpharma.com</a>.   For Media Inquiries: Dave Belian Lexicon Pharmaceuticals, Inc. <a href="https://www.globenewswire.com/Tracker?data=b9gasg5wuoGEWj3yg_nP1YfOZT1VsBJVdeTCBoHeU2fkzhSJLECgmBS3Qb26ujgLNVMekROHpLw1PmdhUf0g9f_dl0PbrQ2FFzVhm06Q57U=" rel="nofollow" target="_blank" title="lexinvest@lexpharma.com">lexinvest@lexpharma.com</a> For Investor Inquiries: Lisa DeFrancesco Lexicon Pharmaceuticals, Inc. <a href="https://www.globenewswire.com/Tracker?data=b9gasg5wuoGEWj3yg_nP1YfOZT1VsBJVdeTCBoHeU2dpUCFNxCtnSDEUx0DnzjDZ21TsggiurWOOyspxKb08IVc9-2zrEDV21wbkR86mJDo=" rel="nofollow" target="_blank" title="lexinvest@lexpharma.com">lexinvest@lexpharma.com</a> <img alt="" src='https://ml.globenewswire.com/media/NjM4MzFjZDktNzA5Yi00MjI3LWJiNmUtYmQ5ZWY0MTBiNzNiLTEwMTU1NDAtMjAyNi0wNS0xMi1lbg==/tiny/Lexicon-Pharmaceuticals-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn